InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Rolph Timothy, Chief Scientific Officer. Officer active across 1 companies, notably Akero Therapeutics, Inc.. In total, 2 filings have been logged. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
238,339 shares
Common Stock
SEC:0001193125-25-312116·
238,339 shares
Common Stock
SEC:0001193125-25-312116:0·
2 of 2 declarations
About Rolph Timothy
Timothy Rolph is the Chief Scientific Officer at Akero Therapeutics, Inc. He oversees research and development initiatives, ensuring innovation in the development of new treatments. His role is essential for the scientific advancement of the company.
